WASHINGTON (Reuters) - Gleevec, a once-a-day pill that has helped boost the survival rate for some leukemia patients, lowers the risk that a rare stomach cancer will come back by 70 percent, U.S. researchers reported on Thursday.>>> Discuss This Story
